A Comparison of the Laryngeal Mask Airway (LMA) Proseal and LMA Supreme in Children

December 9, 2011 updated by: Narasimhan Jagannathan, Ann & Robert H Lurie Children's Hospital of Chicago

A Randomized Trial Comparing the Laryngeal Mask Airway-SupremeTM With the Laryngeal Mask Airway-ProsealTM in Children

The aim of this randomized prospective study is to compare two laryngeal mask airways with a provision for evacuation of gastric contents, the LMA Proseal and The investigators hypothesize that airway leak pressures with the LMA Proseal will be significantly different (higher) when compared with the LMA Supreme.

Study Overview

Detailed Description

The goal of this study is to compare the LMA Proseal and LMA Supreme in children having surgery. The investigators hypothesize that the airway leak pressures with the LMA Proseal will be superior to the LMA Supreme. Airway leak pressures will be measured by recording the circuit pressure at which equilibrium is reached. The ease of placement of the device and gastric tube, fiberoptic grade of laryngeal view, feasibility of use during positive pressure ventilation, and complications (airway related, gastric insufflation, trauma) will also be assessed.

Study Type

Observational

Enrollment (Actual)

60

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Illinois
      • Chicago, Illinois, United States, 60614
        • Childrens Memorial Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

6 months to 6 years (CHILD)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

Children weighing 10 to 20 kg undergoing surgical or medical procedures under anesthesia requiring a supraglottic airway device

Description

Inclusion Criteria:

  • Children undergoing general anesthesia using a supraglottic airway device
  • weight 10-20 kg
  • age 6 months-6 years

Exclusion Criteria:

  • ASA class IV, V Emergency procedures
  • History of a difficult airway
  • Active gastrointestinal reflux
  • Active upper respiratory tract infection

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
LMA Supreme
LMA Supreme will be placed in children weighing 10-20kg based on a computer generated randomization
Other Names:
  • laryngeal mask airway
LMA proseal
LMA Proseal will be placed in children weighing 10-20kg based on a computer generated randomization
Other Names:
  • laryngeal mask airway

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Airway Leak Pressure
Time Frame: participants will be followed for the duration of anesthesia and after surgery, an expected average of 12 hours
Airway leak pressures will be measured by recording the circuit pressure at which equilibrium is reached when fresh gas flow is delivered at 3L/min when the pressure limiting valve is closed completely.
participants will be followed for the duration of anesthesia and after surgery, an expected average of 12 hours

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Time to secure the airway
Time Frame: participants will be followed for the duration of anesthesia and after surgery, an expected average of 12 hours
From picking up the airway device to bilateral chest expansion and presence of ETCO2
participants will be followed for the duration of anesthesia and after surgery, an expected average of 12 hours
Number of attempts to place the device
Time Frame: participants will be followed for the duration of anesthesia and after surgery, an expected average of 12 hours
number of attempts needed for successful placement will be recorded (maximum of 3 attempts will be considered as a failure)
participants will be followed for the duration of anesthesia and after surgery, an expected average of 12 hours
Fiberoptic grade of laryngeal view
Time Frame: participants will be followed for the duration of anesthesia and after surgery, an expected average of 12 hours
The laryngeal alignment through the devices will be graded using an established scoring system
participants will be followed for the duration of anesthesia and after surgery, an expected average of 12 hours
Gastric insufflation
Time Frame: participants will be followed for the duration of anesthesia and after surgery, an expected average of 12 hours
The presence of gastric insufflations will be assessed during leak pressure testing by using epigastric auscultation
participants will be followed for the duration of anesthesia and after surgery, an expected average of 12 hours
Ease of gastric tube placement
Time Frame: participants will be followed for the duration of anesthesia and after surgery, an expected average of 12 hours
The ease of gastric placement will be timed and assessed using a subjective scale
participants will be followed for the duration of anesthesia and after surgery, an expected average of 12 hours
Fiberoptic view through the gastric tube
Time Frame: participants will be followed for the duration of anesthesia and after surgery, an expected average of 12 hours
The view through the gastric drain tube of the LMA supreme will be assessed and graded using an established scoring system
participants will be followed for the duration of anesthesia and after surgery, an expected average of 12 hours
feasibility of positive pressure ventilation
Time Frame: participants will be followed for the duration of anesthesia and after surgery, an expected average of 12 hours
Peak inspiratory pressure and tidal volumes will be recorded. Maximum peak inspiratory pressure will be the airway leak pressure was determined for each patient
participants will be followed for the duration of anesthesia and after surgery, an expected average of 12 hours
Quality of the airway
Time Frame: participants will be followed for the duration of anesthesia and after surgery, an expected average of 12 hours
The quality of hands free anesthesia will be assessed during maintenance of anesthesia using a previously described scale
participants will be followed for the duration of anesthesia and after surgery, an expected average of 12 hours
Adverse effects
Time Frame: Participants will be followed for the duration of anesthesia and 24 hours postoperatively
complications such as oxygen desaturations, mucosal trauma, reflex activation of the airway, sore throat, dysphonia will be recorded
Participants will be followed for the duration of anesthesia and 24 hours postoperatively

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

October 1, 2011

Primary Completion (ACTUAL)

November 1, 2011

Study Completion (ACTUAL)

November 1, 2011

Study Registration Dates

First Submitted

October 4, 2011

First Submitted That Met QC Criteria

October 6, 2011

First Posted (ESTIMATE)

October 10, 2011

Study Record Updates

Last Update Posted (ESTIMATE)

December 12, 2011

Last Update Submitted That Met QC Criteria

December 9, 2011

Last Verified

December 1, 2011

More Information

Terms related to this study

Other Study ID Numbers

  • PLMA vs SLMA

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Children

Clinical Trials on LMA Proseal: control device

Subscribe